Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma.

Alimentary pharmacology & therapeutics(2023)

引用 0|浏览22
暂无评分
摘要
Among patients with uICC, ICI-chemo or ICI-target provided more survival benefits than Chemo while achieving comparable prognoses and fewer adverse events than ICI-target-chemo.
更多
查看译文
关键词
chemotherapy, combination therapy, immune checkpoint inhibitor, immunotherapy, intrahepatic cholangiocarcinoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要